Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.05 (+13.21%)
Close on Nov 17, 2026Market cap $51.44MP/E –Yield –
Milestone Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $559.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $238.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
See a number that looks wrong?